Peptide Library
👋 Hi! I'm GHK-Cu.
I've been studied in scientific research for over 50 years. Let me show you why researchers are still interested in me.
🧬 GHK-Cu
🧪 GHK-Cu — The Skin & Recovery Scientist
What is GHK-Cu?
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper peptide that has been studied for decades in scientific research.
Scientists continue investigating its role in normal biological processes involving:
🧬 Skin Biology
🧪 Collagen Research
💇 Hair Research
🦴 Connective Tissue
⚙️ Cellular Communication
🔬 Research Spotlight
Researchers have studied GHK-Cu for more than 50 years, making it one of the most extensively researched copper peptides in scientific literature.
Quick Facts
📅 First discovered: 1973
🔬 Type: Naturally occurring copper peptide
📚 Research history: 50+ years
🧪 Classification: Research peptide
🧪 Scientist's Note
"Think of me as the body's maintenance specialist. Researchers have spent decades studying how I interact with normal biological processes related to skin, connective tissue, and cellular signaling."
This information is provided for educational purposes and summarizes published scientific research. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding medical decisions.
⚖️ Retatrutide
The Metabolism Scientist
What is Retatrutide?
Retatrutide is an investigational peptide designed to activate three hormone receptors involved in energy balance and metabolism: GLP-1, GIP, and glucagon receptors. Researchers are studying how this "triple agonist" may influence appetite regulation, energy expenditure, blood sugar control, and body weight.
🔬 Research Spotlight
Retatrutide has shown promising results in clinical trials investigating obesity and metabolic health. Because it targets three different metabolic pathways simultaneously, researchers are exploring whether it may offer greater effects than medications that activate only one or two receptors. It remains under clinical investigation and has not received FDA approval for general clinical use.
📊 Quick Facts
📅 Developer: Eli Lilly & Company
🧬 Type: Triple Hormone Receptor Agonist
⚙️ Targets: GLP-1 • GIP • Glucagon Receptors
🧪 Current Status: Investigational (Clinical Research)
🎯 Research Focus: Obesity, metabolism, and blood sugar regulation
🧪 Scientist's Note
"I'm the Metabolism Scientist! Researchers are studying how activating three key hormone pathways at once may influence appetite, energy use, and metabolic function. While the research is exciting, scientists are continuing to evaluate my safety and effectiveness in clinical trials."
📚 Educational Disclaimer
This content is provided for educational purposes only and summarizes current scientific research. Retatrutide is an investigational medication and may not be approved for all uses. This information is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional for medical guidance.
🧬 Tesamorelin
The Visceral Fat Scientist
What is Tesamorelin?
Tesamorelin is a synthetic peptide that mimics the body's natural growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to release growth hormone, which researchers have studied for its effects on metabolism and body composition.
Scientists continue to investigate Tesamorelin's role in regulating visceral fat and supporting healthy metabolic function.
🔬 Research Spotlight
Tesamorelin has been extensively studied for its ability to reduce visceral adipose tissue (VAT)—the fat that surrounds internal organs. Research has also explored its effects on growth hormone secretion, IGF-1 levels, and metabolic health in specific patient populations.
📊 Quick Facts
📅 FDA Approved: 2010 (for a specific medical indication)
🧪 Type: Growth Hormone-Releasing Hormone (GHRH) Analog
🫀 Primary Research Focus: Visceral fat metabolism
📚 Research Areas: Body composition, metabolism, growth hormone physiology
🧪 Scientist's Note
"Hi! I'm Tesamorelin. Think of me as the body's metabolism instructor. Researchers study how I help signal the release of growth hormone and how that may influence visceral fat and body composition."
This content is for educational purposes only and summarizes published scientific research. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding health-related decisions.
